| (Values in U.S. Thousands) | Jun, 2023 | Jun, 2022 | Jun, 2021 | Jun, 2020 | Jun, 2019 |
| Sales | 110 | 0 | 6,490 | 9,930 | 9,280 |
| Sales Growth | unch | -100.00% | -34.64% | +7.00% | +41.68% |
| Net Income | -410 | -350 | 1,290 | 3,550 | 3,310 |
| Net Income Growth | -17.14% | -127.13% | -63.66% | +7.25% | +1,134.38% |
China Health Industries Holdings Inc (CHHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
China Health Industries Holdings Inc. is a manufacturer of health food products through its subsidiaries Harbin Humankind Biology Technology Co., Limited and Heilongjiang Huimeijia Pharmaceutical Co., Ltd. The Company's operating segments consists of Humankind, HLJ Huimeijia and others. Humankind is engaged in the manufacturing and sale of health products. HLJ Huimeijia is involved in the manufacturing and distribution of tincture; ointments; rubber paste, including hormones; topical solution, suppositories, liniment, including traditional Chinese medicine extractions; enemas and oral liquids. China Health Industries Holdings Inc. is based in Harbin City, the Peoples Republic of China.
Fiscal Year End Date: 06/30